News Sentiment

CJMB sentiment intelligence

Callan JMB Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 58 relevant articles
Exchange NASDAQ United States
Sector Industrials Market context
Industry Integrated Freight & Logistics Read-through group
Latest close 0.77 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

83/100 classification confidence.

Company focus 58

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

-6.1% over one week, -6.7% over four weeks, trend inactive, and below fair value.

Latest direct headline Positive

ASU, Callan JMB Partner to Boost Alabama’s Workforce and Pharmaceutical Industry

Market Reaction

Price moving ahead of tone

63/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 83/100 classification
One-week reaction -6.1% Price reacting lower
Trend fit Trend inactive -6.7% over four weeks
Fair value -76.3% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 12
Neutral 39
Negative 7

Relevance

Why the article matched

Direct first
Direct company coverage 58
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 9
Quiver Quantitative 6
TradingKey 5
Market source 4
dars.gov.et 4
Investing.com 3
TradingView 3
GlobeNewswire 3

Event Lens

What the news is about

Classified themes
Market update 39
Earnings 5
Regulatory and legal 5
Deals and strategy 4
Macro sensitivity 2
Capital return 1
Analyst action 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 58
Alabama State University Direct company coverage

ASU, Callan JMB Partner to Boost Alabama’s Workforce and Pharmaceutical Industry

Alabama State University (ASU) and Callan JMB Inc. are partnering to boost Alabama's workforce and pharmaceutical industry through a new Memorandum of Understanding. This collaboration will establish the Atlas Complex, a 150-acre campus for pharmaceutical manufacturing and logist

Tone
Positive 94/100
Event
Market update
Published
14 Jul 2026 22:51
Source
Alabama State University
Investing.com Nigeria Direct company coverage

Callan JMB partners with Alabama State University on workforce development By Investing.com

Callan JMB Inc. has announced a partnership with Alabama State University to foster workforce development and research at its planned Atlas Complex pharmaceutical campus in Marion, Alabama. This collaboration will establish academic programs, student internships, and faculty-led

Tone
Negative 41/100
Event
Deals and strategy
Published
14 Jul 2026 09:51
Source
Investing.com Nigeria
Market source Direct company coverage

Callan JMB Inc. and Alabama State University Partner to Advance Workforce Development, Research, and Pharmaceutical Innovation at the Atlas Complex

Callan JMB Inc. has announced a strategic partnership with Alabama State University (ASU) to foster workforce development, applied research, and industry collaboration at its Atlas Complex. This collaboration aims to accelerate pharmaceutical onshoring and strengthen domestic sup

Tone
Positive 91/100
Event
Deals and strategy
Published
09 Jul 2026 13:39
Source
Market source
Investing.com Direct company coverage

Callan JMB partners with Alabama State University on workforce development

Callan JMB Inc. has announced a partnership with Alabama State University to foster workforce development and research at its upcoming Atlas Complex pharmaceutical campus in Marion, Alabama. This collaboration aims to provide student internships, faculty-led research, and academi

Tone
Neutral 50/100
Event
Deals and strategy
Published
09 Jul 2026 01:10
Source
Investing.com
Pluang Direct company coverage

Callan JMB partners with Alabama State University to boost pharmaceutical workforce and innovation at Atlas Complex.

Callan JMB Inc. has partnered with Alabama State University to foster pharmaceutical workforce development, research, and innovation at the Atlas Complex in Marion, Alabama. This collaboration aims to integrate higher education with industry, providing students with internships a

Tone
Neutral 50/100
Event
Market update
Published
08 Jul 2026 21:10
Source
Pluang
The Globe and Mail Direct company coverage

Callan JMB Faces Nasdaq Minimum Bid Price Noncompliance

Callan JMB Inc. (CJMB) has been notified by Nasdaq that its common stock is not in compliance with the $1.00 minimum bid price requirement, having traded below this threshold for 30 consecutive business days. The company has an initial 180-day window until December 28, 2026, to r

Tone
Negative 18/100
Event
Market update
Published
06 Jul 2026 14:13
Source
The Globe and Mail
TradingView Direct company coverage

Callan JMB Disclosed Failure to Satisfy a Continued Listing Rule or Standard

Callan JMB (CJMB) received a notice from Nasdaq on June 29, 2026, indicating its failure to meet the $1.00 minimum bid price requirement for 30 consecutive business days. The company has 180 days, until December 28, 2026, to regain compliance by maintaining a closing bid price of

Tone
Negative 30/100
Event
Market update
Published
02 Jul 2026 21:40
Source
TradingView
TradingKey Direct company coverage

Callan JMB Inc (CJMB) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Callan JMB Inc (CJMB), noting that no earnings forecast score is currently available for the company. It mentions the Freight & Logistics Services industry average score is 7.55 and indicates that relevant financial forecasting data

Tone
Neutral 50/100
Event
Earnings
Published
24 Jun 2026 21:09
Source
TradingKey
TradingKey Direct company coverage

Callan JMB Inc (CJMB) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Callan JMB Inc (CJMB), noting its current valuation score is 8.75 and ranks 27th in its industry. It details the company's stock performance, with a P/E ratio of -0.34, and mentions that key data for P/B, P/S, and P/CF ratios have not

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 05:09
Source
TradingKey
TradingKey Direct company coverage

Callan JMB Inc (CJMB) Institutional Confidence

This article provides details on the institutional confidence score for Callan JMB Inc (CJMB), which remained stable at 3.00, with an updated date of June 17, 2026. It lists key institutional shareholders and their changes in shares held, highlighting movements by Creative Planni

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 01:39
Source
TradingKey
TradingKey Direct company coverage

Callan JMB Inc (CJMB) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Callan JMB Inc's (CJMB) dividend and stock split history. It indicates that the company has not distributed any dividends over the past five years and has no recorded stock split events. The page also presents current stock data such as market

Tone
Neutral 50/100
Event
Capital return
Published
17 Jun 2026 06:09
Source
TradingKey
TradingKey Direct company coverage

Callan JMB Inc (CJMB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Callan JMB Inc (CJMB), noting that relevant data regarding business segments, regional revenue, and profit contribution have not yet been disclosed by the company. It displays basic stock information including its current price and ma

Tone
Neutral 50/100
Event
Earnings
Published
17 Jun 2026 06:09
Source
TradingKey
Sahm Direct company coverage

Callan JMB Insiders Still US$80k Away From Original Investment Value

Insiders at Callan JMB Inc. (NASDAQ:CJMB) who purchased US$165.5k worth of shares are still down US$80k despite a recent 14% price gain. Despite the losses, there have been recent insider purchases and no sales, indicating continued confidence in the company. Insiders collectivel

Tone
Positive 61/100
Event
Market update
Published
14 Jun 2026 17:40
Source
Sahm
The Globe and Mail Direct company coverage

Callan JMB Announces Executive Vice President Eric Kash Resignation

Callan JMB Inc. announced the resignation of Executive Vice President and board member Eric Kash on June 5, 2026. His departure was not due to disagreements over company operations or policies, and he will receive a severance of $125,000, along with retaining 187,500 vested stock

Tone
Negative 27/100
Event
Market update
Published
13 Jun 2026 04:10
Source
The Globe and Mail
Stock Titan Direct company coverage

Executive exit at Callan JMB (NASDAQ: CJMB) includes $125K severance and 187,500 options

Callan JMB Inc. announced the resignation of Executive Vice President and director Eric Kash, effective June 5, 2026. The company stated his departure was not due to any disagreement, and he will receive a $125,000 severance package over three months, plus accrued vacation. Kash

Tone
Neutral 50/100
Event
Market update
Published
12 Jun 2026 03:38
Source
Stock Titan
Quiver Quantitative Direct company coverage

Callan JMB Inc. Receives Oregon VFC Program Authorization to Enhance Pediatric Vaccine Logistics and Distribution

Callan JMB Inc. has secured a Vaccines for Children (VFC) Program PIN authorization from the State of Oregon, significantly boosting its capacity to manage and distribute pediatric vaccines and other temperature-sensitive medical supplies. This approval strengthens the company's

Tone
Positive 73/100
Event
Regulatory and legal
Published
11 Jun 2026 12:51
Source
Quiver Quantitative
GlobeNewswire Direct company coverage

Callan JMB Expands Oregon Public Health Support Capabilities Through State VFC Authorization

Callan JMB Inc. has received Vaccines for Children (VFC) Program PIN authorization from the State of Oregon, significantly enhancing its capabilities to store, manage, and distribute pediatric vaccines and other temperature-sensitive medical materials. This approval strengthens t

Tone
Positive 71/100
Event
Regulatory and legal
Published
11 Jun 2026 12:44
Source
GlobeNewswire
Stock Titan Direct company coverage

Oregon approval lets Callan JMB help deliver pediatric vaccines locally

Callan JMB (NASDAQ: CJMB) received authorization from the State of Oregon's Vaccines for Children (VFC) Program, allowing it to store, manage, prepare, and distribute pediatric vaccines and other temperature-sensitive medical materials. This approval strengthens the company's abi

Tone
Positive 72/100
Event
Regulatory and legal
Published
09 Jun 2026 18:40
Source
Stock Titan
Moomoo Direct company coverage

Callan JMB(CJMB) Stock Options Chain | Quotes & News

This article provides details on the stock options chain for Callan JMB (CJMB). It includes quotes and news related to the company's stock performance and market activity. The content specifically focuses on financial information relevant to potential investors or current shareho

Tone
Neutral 50/100
Event
Market update
Published
09 Jun 2026 01:09
Source
Moomoo
Stock Titan Direct company coverage

CALLAN JMB INC. SEC Filing

CALLAN JMB INC. (CJMB) filed an EFFECT notice with the SEC, indicating the effectiveness of its S-3 Shelf Registration Statement as of June 5, 2026, at 5:00 P.M. The filing impact and sentiment are both neutral. This SEC filing relates to the registration of securities for future

Tone
Neutral 50/100
Event
Market update
Published
08 Jun 2026 10:39
Source
Stock Titan
Stock Titan Direct company coverage

Director buys CALLAN JMB (CJMB) shares and receives 25K-share option grant

CALLAN JMB director Gerald Dial executed two equity transactions: an open-market purchase of 10,000 common shares at $0.762 each, increasing his direct holdings to 12,000, and an option grant covering 25,000 shares. The options, granted on the company's IPO day, vest on February

Tone
Positive 65/100
Event
Market update
Published
03 Jun 2026 13:10
Source
Stock Titan
Investing.com Direct company coverage

Callan JMB director Gerald Dial buys $7,620 in company stock

Callan JMB director Gerald Dial recently purchased 10,000 shares of CALLAN JMB INC. (CJMB) common stock for $7,620, while the stock is trading near its 52-week low. Mr. Dial also holds 25,000 deeply out-of-the-money options granted during the company's IPO. These transactions fol

Tone
Neutral 50/100
Event
Market update
Published
03 Jun 2026 01:09
Source
Investing.com